GPC3-targeted PET imaging agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GPC3-targeted PET imaging agent, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma [EARLY_Phase 1]